Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the efficacy of cilostazol in preventing recurrence of cerebral infarction and the safety of long-term administration of the drug (100 mg, twice daily) in patients with cerebral infarction (excluding cardiogenic cerebral embolism) in a multi-center, double-blind, parallel-group comparison with aspirin (81 mg, once daily).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00234065
Study type	Interventional
Source	Otsuka Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 4
Start date	December 2003
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02551003` - Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy	Phase 1/Phase 2
Completed	`NCT03281590` - Stroke and Cerebrovascular Diseases Registry
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Completed	`NCT00684515` - Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)	Phase 2
Not yet recruiting	`NCT04082091` - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Completed	`NCT01915368` - Determining Optimal Post-Stroke Exercise (DOSE)	N/A
Terminated	`NCT01684462` - The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke	Phase 2
Completed	`NCT00386191` - Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment	Phase 4
Completed	`NCT00004734` - Vitamin Therapy for Prevention of Stroke	Phase 3
Completed	`NCT02684825` - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke	N/A
Completed	`NCT02248233` - Nimodipine for Treating Acute Massive Cerebral Infarction	Phase 4
Completed	`NCT02963545` - TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke	N/A
Completed	`NCT02511249` - Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke	N/A
Completed	`NCT02101606` - Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke	Phase 2
Completed	`NCT01500421` - Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund)	Phase 2
Completed	`NCT00829361` - Stroke Telemedicine for Arizona Rural Residents Trial	N/A
Recruiting	`NCT01003470` - Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study	Phase 2
Terminated	`NCT00331890` - ICTUS Study: International Citicoline Trial on Acute Stroke	Phase 3
Not yet recruiting	`NCT04696523` - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage	Phase 2
Completed	`NCT03741400` - Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke	N/A